These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25114240)

  • 1. A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs.
    Prota AE; Bargsten K; Diaz JF; Marsh M; Cuevas C; Liniger M; Neuhaus C; Andreu JM; Altmann KH; Steinmetz MO
    Proc Natl Acad Sci U S A; 2014 Sep; 111(38):13817-21. PubMed ID: 25114240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A previously undescribed tubulin binder.
    Field JJ; Waight AB; Senter PD
    Proc Natl Acad Sci U S A; 2014 Sep; 111(38):13684-5. PubMed ID: 25187564
    [No Abstract]   [Full Text] [Related]  

  • 3. The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization.
    Prota AE; Danel F; Bachmann F; Bargsten K; Buey RM; Pohlmann J; Reinelt S; Lane H; Steinmetz MO
    J Mol Biol; 2014 Apr; 426(8):1848-60. PubMed ID: 24530796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of action of microtubule-stabilizing anticancer agents.
    Prota AE; Bargsten K; Zurwerra D; Field JJ; Díaz JF; Altmann KH; Steinmetz MO
    Science; 2013 Feb; 339(6119):587-90. PubMed ID: 23287720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging the maytansine and vinca sites: Cryptophycins target β-tubulin's T5-loop.
    Abel AC; Mühlethaler T; Dessin C; Schachtsiek T; Sammet B; Sharpe T; Steinmetz MO; Sewald N; Prota AE
    J Biol Chem; 2024 Jun; 300(6):107363. PubMed ID: 38735475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.
    Jordan A; Hadfield JA; Lawrence NJ; McGown AT
    Med Res Rev; 1998 Jul; 18(4):259-96. PubMed ID: 9664292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site.
    Matthew S; Chen QY; Ratnayake R; Fermaintt CS; Lucena-Agell D; Bonato F; Prota AE; Lim ST; Wang X; Díaz JF; Risinger AL; Paul VJ; Oliva MÁ; Luesch H
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubulins - the target for anticancer therapy.
    Vindya NG; Sharma N; Yadav M; Ethiraj KR
    Curr Top Med Chem; 2015; 15(1):73-82. PubMed ID: 25579568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New interfacial microtubule inhibitors of marine origin, PM050489/PM060184, with potent antitumor activity and a distinct mechanism.
    Pera B; Barasoain I; Pantazopoulou A; Canales A; Matesanz R; Rodriguez-Salarichs J; García-Fernandez LF; Moneo V; Jiménez-Barbero J; Galmarini CM; Cuevas C; Peñalva MA; Díaz JF; Andreu JM
    ACS Chem Biol; 2013 Sep; 8(9):2084-94. PubMed ID: 23859655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubulin Maytansine Site Binding Ligands and their Applications as MTAs and ADCs for Cancer Therapy.
    Cao S; Dong YH; Wang DF; Liu ZP
    Curr Med Chem; 2020; 27(27):4567-4576. PubMed ID: 32175831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hallmarks of molecular action of microtubule stabilizing agents: effects of epothilone B, ixabepilone, peloruside A, and laulimalide on microtubule conformation.
    Khrapunovich-Baine M; Menon V; Yang CP; Northcote PT; Miller JH; Angeletti RH; Fiser A; Horwitz SB; Xiao H
    J Biol Chem; 2011 Apr; 286(13):11765-78. PubMed ID: 21245138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis of Microtubule Stabilization by Discodermolide.
    Prota AE; Bargsten K; Redondo-Horcajo M; Smith AB; Yang CH; McDaid HM; Paterson I; Horwitz SB; Fernando Díaz J; Steinmetz MO
    Chembiochem; 2017 May; 18(10):905-909. PubMed ID: 28207984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Insights into the Pharmacophore of Vinca Domain Inhibitors of Microtubules.
    Wang Y; Benz FW; Wu Y; Wang Q; Chen Y; Chen X; Li H; Zhang Y; Zhang R; Yang J
    Mol Pharmacol; 2016 Feb; 89(2):233-42. PubMed ID: 26660762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization.
    Khrapunovich-Baine M; Menon V; Verdier-Pinard P; Smith AB; Angeletti RH; Fiser A; Horwitz SB; Xiao H
    Biochemistry; 2009 Dec; 48(49):11664-77. PubMed ID: 19863156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fluorescence anisotropy assay to discover and characterize ligands targeting the maytansine site of tubulin.
    Menchon G; Prota AE; Lucena-Agell D; Bucher P; Jansen R; Irschik H; Müller R; Paterson I; Díaz JF; Altmann KH; Steinmetz MO
    Nat Commun; 2018 May; 9(1):2106. PubMed ID: 29844393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high-resolution X-ray structure of vinca-domain inhibitors of microtubules provides a rational approach for drug design.
    Chengyong W; Jinghong X; Yanyan W; Qing-Jie X; Lingling M; Yuyan L; Hai C; Qian L; Quan Z; Bo S; Yuxi W
    FEBS Lett; 2021 Jan; 595(2):195-205. PubMed ID: 33220079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pironetin Binds Covalently to αCys316 and Perturbs a Major Loop and Helix of α-Tubulin to Inhibit Microtubule Formation.
    Prota AE; Setter J; Waight AB; Bargsten K; Murga J; Diaz JF; Steinmetz MO
    J Mol Biol; 2016 Jul; 428(15):2981-8. PubMed ID: 27395016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A unique mode of microtubule stabilization induced by peloruside A.
    Huzil JT; Chik JK; Slysz GW; Freedman H; Tuszynski J; Taylor RE; Sackett DL; Schriemer DC
    J Mol Biol; 2008 May; 378(5):1016-30. PubMed ID: 18405918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution X-ray structure of three microtubule-stabilizing agents in complex with tubulin provide a rationale for drug design.
    Xiao Q; Xue T; Shuai W; Wu C; Zhang Z; Zhang T; Zeng S; Sun B; Wang Y
    Biochem Biophys Res Commun; 2021 Jan; 534():330-336. PubMed ID: 33272565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting microtubule targeting agents: α-Tubulin and the pironetin binding site as unexplored targets for cancer therapeutics.
    Coulup SK; Georg GI
    Bioorg Med Chem Lett; 2019 Aug; 29(15):1865-1873. PubMed ID: 31130264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.